Dr. Tarek Shalaby, Editor-in-Chief of the Journal of Unexplored Medical Data, Visited the OAE Publishing Inc. Beijing office for a Strategic Meeting
On June 26, 2017, Dr. Tarek Shalaby, Editor-in-Chief of the Journal of Unexplored Medical Data (JUMD), visited the Beijing office of OAE Publishing Inc. and discussed the development of JUMD.
Those who were present included Dr. Tarek Shalaby and Mrs. Shalaby; Min Fan, Chairman of the OAE Publishing Inc.; Dandan Yu, Assistant Publisher; Lisa Huang and Carrie Wang, Managing Editors, and Jie Feng, Assistant Editor of JUMD.
First, Dandan Yu and Jie Feng reported the development and status of OAE and JUMD, respectively. Then, Dr. Tarek Shalaby talked about his ideas on the development of JUMD. Dr. Shalaby said that most published articles in other journals describe merely positive results, as negative results and repeated experiments are rarely published. The majority of researchers failed to reveal negative data or abandoned them. Neither the authors nor the publishers of traditional journals want to publish this type of data. However, this does not indicate that these data are of no value and significance. In contrast, the publication of negative data and repeated experiments can help researchers avoid duplication of errors, in addition to saving time and money. Second, Dr. Shalaby said that the positive results are based on a large number of negative data and failed experiments. The data we now see are only the tip of the data iceberg generated by the scientific community. Because of this, the emergence of JUMD is to dig out these meaningful data and present them to researchers in the medical field to share, exchange, promote scientific progress, and reduce the chance of experimental failure.
（From left: Carrie Wang, Dandan Yu, Dr. Tarek Shalaby, Min Fan, Jie Feng, Lisa Huang）
Finally, Dr. Shalaby showed his expectation that through promotions and publicity speeches at meetings etc., JUMD can be widely known by more researchers so as to encourage them to present their valuable and useful data in JUMD.
At the end of the meeting, Mr. Fan discussed with Dr. Shalaby how to collect enough data to improve the influence of the journal, how to publicize, as well as the future direction of development of JUMD. Fortunately, Mr. Fan and Dr. Shalaby have the same goals regarding journal planning. Meanwhile, Dr. Shalaby has provided good promotional advice for JUMD and said he is willing to advertise JUMD by attending meetings.
Through this meeting, we have a clearer goal of JUMD development and believe that JUMD will become the only journal to publish both negative and positive data, and repeated experiments in the medical field.